Transcriptome_analysis_of_anaplastic_meningiomas
EGAS00001001873, EGAD00001003255Collord et al., 2018
Overview
- Modality
- Bulk RNA-seq
- Sample count
- 31
- Patient count
- 28
- Institution
- Wellcome Sanger Institute / Cambridge University Hospitals NHS Foundation Trust
- Corresponding author
- Thomas Santarius / Ultan McDermott
- Platform
- Illumina HiSeq 2500
- Access type
- controlled
- Tissue preservation
- Not reported
- WHO edition
- Not reported
- Ontology
- Disease: MONDO:0020635 · Tissue: UBERON:0003547
Cohort detail
- Grade breakdown
- G1: 0 G2: 0 G3: 31
- Sex distribution
- Not reported
- Age distribution
- Not reported
- Anatomic location
- Not reported
- Brain invasion
- Not reported
- Normal/control tissue
- None
Priority attributes
Linked to other modalitiesPrimary vs. recurrent annotatedMolecular subtype annotatedOutcome/survival dataPeer-reviewed
Publications
- Collord G, et al. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Scientific Reports, 2018. PMID 30202034 · DOI
Related datasets
Sources
- EGA study pagehttps://ega-archive.org/studies/EGAS00001001873
- EGA dataset pagehttps://ega-archive.org/datasets/EGAD00001003255
- PubMedhttps://pubmed.ncbi.nlm.nih.gov/30202034/
- DOIhttps://doi.org/10.1038/s41598-018-31659-0